Press releases
* (R) = Regulatory press releases
23 May, 2022
(R) Annual General Meeting in Cantargia AB (publ)
17 May, 2022
Invitation to presentation of Cantargia’s report for the first quarter of 2022 on May 23 at 10.00 a.m. CET
27 Apr, 2022
(R) Cantargia to present new clinical data on lead IL1RAP antibody nadunolimab over three sessions at ASCO 2022
10 Mar, 2022